Midas Medici Group Holdings, Inc. (OTC:MMED) is another company that has got into the spotlight of promoters this week.
Yesterday, the company was once again promoted, which is a continuation of the promotional effort on Friday. Apparently, the $10 thousand promotional campaign sponsored by Trilogy Capital is still going on.
On Friday, MMED generated only 1,400 shares in volume, which gave no clue to the common investors that the company was under the effect of a paid advertising campaign. Moreover, the company not only was unable to generate more trading activity but it also lost 10% of its stock value as the share price dropped .40% and 9.60% on Friday and Monday respectively.[BANNER]
The paradox of the market performance of MMED comes from 
the fact that the company has just announced a $3 million contract for data center solutions in Brazil. Apparently, the company has been out of the focus on the market and unfortunately neither the announcement nor the promotion were able to change that.
Therefore, it will be hardly probable that the promotion will work out in the coming session too. Anyway, the most visible problem for the company at this stage is its low trading activity, which makes MMED stock price easy to manipulate.
